Oryzon Genomics Eulerpool Новини

Oryzon Genomics Eulerpool News

Oryzon Genomics Новини за акции

Oryzon Genomics се наблюдава от множество журналисти и инвеститори по целия свят. Най-актуалните Oryzon Genomics новини събираме тук.

• 3 септември ·

  Yahoo
  ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional “Decision to Grant” Communications
• 29 август ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in September
• 31 юли ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8 юли ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28 юни ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26 юни ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14 юни ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3 юни ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• 30 май ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• 29 май ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)